Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH) recently reported data on eravacycline, which is currently under review by the United States Food ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE